SCHEMBL6970107

SCHEMBL6970107

CCN(CCN(C)C)c1ccc(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 13/20 0.58
PRKD3 O94806 4/20 0.58
PRKCG P05129 4/20 0.58
PRKCB P05771 4/20 0.58
LCK P06239 4/20 0.58
PRKCA P17252 4/20 0.58
PRKCH P24723 4/20 0.58
PRKCI P41743 4/20 0.58
PRKCE Q02156 4/20 0.58
PRKCQ Q04759 4/20 0.58
PRKCZ Q05513 4/20 0.58
PRKCD Q05655 4/20 0.58
PRKD1 Q15139 4/20 0.58
EGFR P00533 3/20 0.58
CDK2 P24941 4/20 0.57
JAK2 O60674 1/20 0.57
PIK3CA P42336 1/20 0.57
PIK3CB P42338 1/20 0.57
PIK3CG P48736 1/20 0.57
PTK2B Q14289 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978350 0.90 ZAP70 (0.61) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL4891528 0.85 ZAP70 (0.69) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6968545 0.81 ZAP70 (0.60) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6974678 0.81 ZAP70 (0.79) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL2233317 0.81 ZAP70 (0.69) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6970247 0.79 CDK2 (0.66) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6980078 0.78 ZAP70 (0.76) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6977338 0.78 CDK2 (0.65) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6952024 0.77 EGFR (0.77) ZAP70PRKD3PRKCGPRKCBLCK
SCHEMBL6974718 0.76 ZAP70 (0.74) ZAP70PRKD3PRKCGPRKCBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed